| Date | Form | Description | Docs | XBRL | Pages |
| 03/16/12 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
|
44 |
| 11/30/11 | 10-Q/A | Quarterly report pursuant to sections 13 or 15(d) |
|
36 | |
| 10/14/11 | 10-Q/A | Quarterly report pursuant to sections 13 or 15(d) |
|
|
3 |
| 09/14/11 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
79 | |
| 06/14/11 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
56 | |
| 03/17/11 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
52 | |
| 09/14/10 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
58 | |
| 09/14/10 | 10-Q/A | Quarterly report pursuant to sections 13 or 15(d) |
|
14 | |
| 06/14/10 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
58 | |
| 03/17/10 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
47 |
Latest News & Events
Anixa Biosciences and OntoChem Enter Next Stage of Development for Covid-19 Therapeutic
Read More...Anixa Biosciences Increases Previously Announced Bought Deal Offering of Common Stock to $22.5 Million
Read More...Anixa Biosciences Announces $10 Million Bought Deal Offering of Common Stock
Read More...